UNSPSC 51102807: Acetic acid/desonide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT250. This VA Drug Class (OT250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OTIC.

UNSPSC 51102807 Acetic acid/desonide is a Commodity code that in recent state and local procurement activity covers emergency medical supplies, pharmaceuticals, and over-the-counter products rather than the narrow chemical compound its name suggests. State and local buyers soliciting under this code include county health departments, city fire departments, and multistate cooperative purchasing alliances that aggregate demand across state agencies and local governments. The Seminole County, Florida IFB for naloxone and drug deactivation systems (1,900 units of naloxone and 800 safe drug deactivation systems annually), the City of Tampa IFB for medical and first aid supplies to the Fire Department Rescue Division (169 line items including respiratory equipment, cardiac monitoring electrodes, and consumables), and the Minnesota Multistate Cooperative Purchasing Alliance RFP for generic multi-source pharmaceuticals and OTC products reflect the actual scope of procurement activity—emergency response consumables and pharmaceutical inventory for public health and safety operations. These opportunities show solicitation through both individual municipalities and regional cooperative purchasing vehicles, with awards typically structured as fixed-price contracts with one- to two-year initial terms and renewal options.

Recent activity concentrates in Florida and Minnesota, with broader reach through multistate cooperative purchasing programs. The Seminole County opportunity (IFB 60459723LAS, response due July 26, 2023) carries an estimated annual volume of 1,900 units of naloxone with quarterly deliveries; the City of Tampa opportunity (Bid 26-P-00145, due March 13, 2026) was an estimated $700,000 sheltered market procurement reserved for certified Small Local Business Enterprises with a 5 percent bid discount; and the MMCAP RFP (S1070000015802, due March 26, 2026) sought multiple-award contracts for generic pharmaceuticals and OTC products across participating Minnesota and Oregon state and local facilities, with products to be available through authorized wholesalers by May 15, 2026. The Texas Health and Human Services Commission's April 2026 RFI (HHS0017013) represents exploratory procurement for direct-to-manufacturer prescription programs serving state employees and health plans, signaling future formal solicitation once vendor capabilities are assessed. Vendors competing in this code face requirements for pharmaceutical licensing, cGMP and DSCSA compliance, established distributor relationships, and significant liability insurance coverage.